Emerging Approaches in Neuro and Neuropsychiatric Therapeutics: Innovative Drug Discovery and Drug Delivery Strategies
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".
Deadline for manuscript submissions: 20 February 2026 | Viewed by 36
Special Issue Editors
Interests: drug reposition; drug repurposing; polypharmacology; bioinformatics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The discovery and delivery of drugs for central nervous system disorders is undoubtedly a persistent challenge. However, major advances have been made in this field in recent years, spanning the approval of small molecules for rare genetic brain disorders to the commercialization of monoclonal antibodies with disease-modifying potential against neurodegenerative diseases, and ranging from targeted delivery to gene therapies.
This volume invites original and review articles on the pharmaceutical design, formulation, and delivery of small and large molecules for neurological and neuropsychiatric disorders. Contributions should highlight drug delivery technologies, drug development, and formulation strategies with therapeutic potential for neurological diseases.
Prof. Dr. Alan Talevi
Dr. Carolina Bellera
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- central nervous system
- brain
- therapeutics
- drug delivery
- drug discovery
- drug design
- targeted delivery
- brain delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
